FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:79-85 January 8, 1998 Number 2 Next

	Full Text PDF Editorial by Rosenthal, N. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background High blood levels of coagulation factor VII are associated with a risk of ischemic vascular disease. Although factor VII levels may be genetically determined, the relation between genetic polymorphisms of factor VII, factor VII blood levels, and the risk of myocardial infarction has not been established.

Methods We performed a case–control study of 165 patients with familial myocardial infarction (mean [±SD] age, 55±9 years) and 225 controls without a personal or family history of cardiovascular disease (mean age, 56±8 years). The polymorphisms involving R353Q and hypervariable region 4 of the factor VII gene were studied. Factor VII clotting activity and antigen levels were also measured.

Results Patients with the QQ or H7H7 genotype had a decreased risk of myocardial infarction (odds ratios, 0.08 [95 percent confidence interval, 0.01 to 0.9] and 0.22 [95 percent confidence interval, 0.08 to 0.63], respectively). For the R353Q polymorphism, the RR genotype was associated with the highest risk, followed by the RQ genotype and then by the QQ genotype (P<0.001). For the polymorphism involving hypervariable region 4, the combined H7H5 and H6H5 genotypes were associated with the highest risk, followed in descending order by the H6H6, H6H7, and H7H7 genotypes (P<0.001). Patients with the QQ or H7H7 genotype had lower levels of both factor VII antigen and factor VII clotting activity than those with the RR or H6H6 genotype. Patients with the lowest level of factor VII clotting activity had a lower risk of myocardial infarction than those with the highest level (odds ratio, 0.13; 95 percent confidence interval, 0.05 to 0.34).

Conclusions Our findings suggest that certain polymorphisms of the factor VII gene may influence the risk of myocardial infarction. It is possible that this effect may be mediated by alterations in factor VII levels.

Source Information

From the Unit of the Genetics of Vascular Risk Factors, Angela Valenti Laboratory of Thrombosis Pharmacology, Department of Vascular Medicine and Pharmacology (L.I., A.D.C., A.D'O., C.A., M.B.D.), and the Laboratory of Drug Epidemiology, Department of Clinical Pharmacology and Epidemiology (R.A.), Istituto di Ricerche Farmacologiche Mario Negri, Santa Maria Imbaro, Italy; and Gaubius Laboratory (L.I., P. de K., C.K.) and Medical Center of Genetics –Department of Human Genetics, Leiden University (P. de K.), Leiden, the Netherlands.

Address reprint requests to Dr. Iacoviello at Angela Valenti Laboratory of Thrombosis Pharmacology, Department of Vascular Medicine and Pharmacology, Consorzio Mario Negri Sud, 66030 Santa Maria Imbaro, Italy.

Full Text of this Article

This article has been cited by other articles:

• Ferraresi, P., Campo, G., Marchetti, G., Pinotti, M., Valgimigli, M., Gemmati, D., Ferrari, R., Bernardi, F. (2009). Temporal and Genotype-Driven Variation of Factor VII Levels in Patients With Acute Myocardial Infarction. CLIN APPL THROMB HEMOST 15: 119-122  
• Jackson, A. A., Cronin, K. R., Zachariah, R., Carew, J. A. (2007). CCAAT/Enhancer-binding Protein-beta Participates in Insulin-responsive Expression of the Factor VII Gene. J. Biol. Chem. 282: 31156-31165 [Abstract] [Full Text]  
• Campo, G., Valgimigli, M., Ferraresi, P., Malagutti, P., Baroni, M., Arcozzi, C., Gemmati, D., Percoco, G., Parrinello, G., Ferrari, R., Bernardi, F. (2006). Tissue Factor and Coagulation Factor VII Levels During Acute Myocardial Infarction: Association With Genotype and Adverse Events. Arterioscler. Thromb. Vasc. Bio. 26: 2800-2806 [Abstract] [Full Text]  
• Rip, J., Nierman, M. C., Ross, C. J., Jukema, J. W., Hayden, M. R., Kastelein, J. J.P., Stroes, E. S.G., Kuivenhoven, J. A. (2006). Lipoprotein Lipase S447X: A Naturally Occurring Gain-of-Function Mutation. Arterioscler. Thromb. Vasc. Bio. 26: 1236-1245 [Abstract] [Full Text]  
• Funk, M., Endler, G., Lalouschek, W., Hsieh, K., Schillinger, M., Lang, W., Mannhalter, C. (2006). Factor VII Gene Haplotypes and Risk of Ischemic Stroke. Clin. Chem. 52: 1190-1192 [Abstract] [Full Text]  
• Andreotti, F., Becker, R. C. (2005). Atherothrombotic Disorders: New Insights From Hematology. Circulation 111: 1855-1863 [Full Text]  
• Iacoviello, L., Di Castelnuovo, A., Gattone, M., Pezzini, A., Assanelli, D., Lorenzet, R., Del Zotto, E., Colombo, M., Napoleone, E., Amore, C., D'Orazio, A., Padovani, A., de Gaetano, G., Giannuzzi, P., Donati, M.B., on behalf of IGIGI Investigators, (2005). Polymorphisms of the Interleukin-1{beta} Gene Affect the Risk of Myocardial Infarction and Ischemic Stroke at Young Age and the Response of Mononuclear Cells to Stimulation In Vitro. Arterioscler. Thromb. Vasc. Bio. 25: 222-227 [Abstract] [Full Text]  
• White, T. O., Jenkins, P. J., Smith, R. D., Cartlidge, C. W.J., Robinson, C. M. (2004). The Epidemiology of Posttraumatic Adult Respiratory Distress Syndrome. JBJS 86: 2366-2376 [Abstract] [Full Text]  
• Sass, C., Blanquart, C., Morange, P.-E., Pfister, M., Visvikis-Siest, S. (2004). Association Between Factor VII Polymorphisms and Blood Pressure: The Stanislas Cohort. Hypertension 44: 674-680 [Abstract] [Full Text]  
• McCarthy, J J, Parker, A, Salem, R, Moliterno, D J, Wang, Q, Plow, E F, Rao, S, Shen, G, Rogers, W J, Newby, L K, Cannata, R, Glatt, K, Topol, E J (2004). Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. J. Med. Genet. 41: 334-341 [Abstract] [Full Text]  
• Zee, R. Y.L., Cook, N. R., Cheng, S., Reynolds, R., Erlich, H. A., Lindpaintner, K., Ridker, P. M. (2004). Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis. Hum Mol Genet 13: 389-396 [Abstract] [Full Text]  
• Voetsch, B., Loscalzo, J. (2004). Genetic Determinants of Arterial Thrombosis. Arterioscler. Thromb. Vasc. Bio. 24: 216-229 [Abstract] [Full Text]  
• Yamada, Y., Izawa, H., Ichihara, S., Takatsu, F., Ishihara, H., Hirayama, H., Sone, T., Tanaka, M., Yokota, M. (2002). Prediction of the Risk of Myocardial Infarction from Polymorphisms in Candidate Genes. NEJM 347: 1916-1923 [Abstract] [Full Text]  
• Santacroce, R., Ratti, A., Caroli, F., Foglieni, B., Ferraris, A., Cremonesi, L., Margaglione, M., Seri, M., Ravazzolo, R., Restagno, G., Dallapiccola, B., Rappaport, E., Pollak, E. S., Surrey, S., Ferrari, M., Fortina, P. (2002). Analysis of Clinically Relevant Single-Nucleotide Polymorphisms by Use of Microelectronic Array Technology. Clin. Chem. 48: 2124-2130 [Abstract] [Full Text]  
• Mills, J.D., Mansfield, M.W., Grant, P.J. (2002). Elevated fibrinogen in the healthy male relatives of patients with severe, premature coronary artery disease. Eur Heart J 23: 1276-1281 [Abstract]  
• Tarumi, T., Kravtsov, D. V., Zhao, M., Williams, S. M., Gailani, D. (2002). Cloning and Characterization of the Human Factor XI Gene Promoter. TRANSCRIPTION FACTOR HEPATOCYTE NUCLEAR FACTOR 4alpha (HNF-4alpha ) IS REQUIRED FOR HEPATOCYTE-SPECIFIC EXPRESSION OF FACTOR XI. J. Biol. Chem. 277: 18510-18516 [Abstract] [Full Text]  
• Braunstein, J. B., Kershner, D. W., Bray, P., Gerstenblith, G., Schulman, S. P., Post, W. S., Blumenthal, R. S. (2002). Interaction of Hemostatic Genetics With Hormone Therapy : New Insights To Explain Arterial Thrombosis in Postmenopausal Women. Chest 121: 906-920 [Abstract] [Full Text]  
• Salomaa, V., Rasi, V., Kulathinal, S., Vahtera, E., Jauhiainen, M., Ehnholm, C., Pekkanen, J. (2002). Hemostatic Factors as Predictors of Coronary Events and Total Mortality: The FINRISK '92 Hemostasis Study. Arterioscler. Thromb. Vasc. Bio. 22: 353-358 [Abstract] [Full Text]  
• Herrington, D. M., Klein, K. P. (2001). Genome and Hormones: Gender Differences in Physiology: Invited Review: Pharmacogenetics of estrogen replacement therapy. J. Appl. Physiol. 91: 2776-2784 [Abstract] [Full Text]  
• Ortlepp, J R, Hoffmann, R, Ohme, F, Lauscher, J, Bleckmann, F, Hanrath, P (2001). The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 85: 635-638 [Abstract] [Full Text]  
• Corral, J., Iniesta, J. A., Gonzalez-Conejero, R., Villalon, M., Vicente, V. (2001). Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage. Blood 97: 2979-2982 [Abstract] [Full Text]  
• Williams, M. S., Bray, P. F. (2001). Genetics of Arterial Prothrombotic Risk States. Exp. Biol. Med. 226: 409-419 [Abstract] [Full Text]  
• Sykes, T C F, Fegan, C, Mosquera, D (2000). Thrombophilia, polymorphisms, and vascular disease. Mol. Pathol. 53: 300-306 [Abstract] [Full Text]  
• Mrozikiewicz, P. M., Cascorbi, I., Ziemer, S., Laule, M., Meisel, C., Stangl, V., Rutsch, W., Wernecke, K., Baumann, G., Roots, I., Stangl, K. (2000). Reduced procedural risk for coronary catheter interventions in carriers of the coagulation factor VII-Gln353 gene. J Am Coll Cardiol 36: 1520-1525 [Abstract] [Full Text]  
• Press, R. D. (2000). Detection of Prevalent Genetic Alterations Predisposing to Hemochromatosis and Other Common Human Diseases. Clin. Chem. 46: 1526-1528 [Full Text]  
• Girelli, D., Russo, C., Ferraresi, P., Olivieri, O., Pinotti, M., Friso, S., Manzato, F., Mazzucco, A., Bernardi, F., Corrocher, R. (2000). Polymorphisms in the Factor VII Gene and the Risk of Myocardial Infarction in Patients with Coronary Artery Disease. NEJM 343: 774-780 [Abstract] [Full Text]  
• Souto, J. C., Almasy, L., Muniz-Diaz, E., Soria, J. M., Borrell, M., Bayen, L., Mateo, J., Madoz, P., Stone, W., Blangero, J., Fontcuberta, J. (2000). Functional Effects of the ABO Locus Polymorphism on Plasma Levels of von Willebrand Factor, Factor VIII, and Activated Partial Thromboplastin Time. Arterioscler. Thromb. Vasc. Bio. 20: 2024-2028 [Abstract] [Full Text]  
• Pinotti, M., Toso, R., Girelli, D., Bindini, D., Ferraresi, P., Papa, M. L., Corrocher, R., Marchetti, G., Bernardi, F. (2000). Modulation of factor VII levels by intron 7 polymorphisms: population and in vitro studies. Blood 95: 3423-3428 [Abstract] [Full Text]  
• Iacoviello, L., Donati, M. B., Gattone, M., Crossman, D. C., Francis, S. E., Camp, N. J., Dewberry, R. M., Gunn, J., Cumberland, D. C., Duff, G. W., Syrris, P., Carter, N. D., Jeffery, S., Kaski, J. C. (2000). Possible Different Involvement of Interleukin-1 Receptor Antagonist Gene Polymorphism in Coronary Single Vessel Disease and Myocardial Infarction Response. Circulation 101 : e193-e193 [Full Text]  
• Soria, J. M., Almasy, L., Souto, J. C., Tirado, I., Borell, M., Mateo, J., Slifer, S., Stone, W., Blangero, J., Fontcuberta, J. (2000). Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis. Blood 95: 2780-2785 [Abstract] [Full Text]  
• Lane, D. A., Grant, P. J. (2000). Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 95: 1517-1532 [Full Text]  
• Feng, D., Tofler, G. H., Larson, M. G., O’Donnell, C. J., Lipinska, I., Schmitz, C., Sutherland, P. A., Johnstone, M. T., Muller, J. E., D’Agostino, R. B., Levy, D., Lindpaintner, K. (2000). Factor VII Gene Polymorphism, Factor VII Levels, and Prevalent Cardiovascular Disease : The Framingham Heart Study. Arterioscler. Thromb. Vasc. Bio. 20: 593-600 [Abstract] [Full Text]  
• Kario, K., Matsuo, M., Miyata, T. (2000). Are There Any Associations Among Coagulation Factor VII Gene Polymorphism, Plasma Activated Factor VII Levels, and Cerebrovascular Disease?. Circulation 101 : e48-e48 [Full Text]  
• Mira, J.-P., Cariou, A., Grall, F., Delclaux, C., Losser, M.-R., Heshmati, F., Cheval, C., Monchi, M., Teboul, J.-L., Riche, F., Leleu, G., Arbibe, L., Mignon, A., Delpech, M., Dhainaut, J.-F. (1999). Association of TNF2, a TNF-{alpha} Promoter Polymorphism, With Septic Shock Susceptibility and Mortality: A Multicenter Study. JAMA 282: 561-568 [Abstract] [Full Text]  
• Ardissino, D., Mannucci, P.M., Merlini, P.A., Duca, F., Fetiveau, R., Tagliabue, L., Tubaro, M., Galvani, M., Ottani, F., Ferrario, M., Corral, J., Margaglione, M. (1999). Prothrombotic Genetic Risk Factors in Young Survivors of Myocardial Infarction. Blood 94: 46-51 [Abstract] [Full Text]  
• Maresca, G., Di Blasio, A., Marchioli, R., Di Minno, G. (1999). Measuring Plasma Fibrinogen to Predict Stroke and Myocardial Infarction : An Update. Arterioscler. Thromb. Vasc. Bio. 19: 1368-1377 [Abstract] [Full Text]  
• Moss, A. J., Goldstein, R. E., Marder, V. J., Sparks, C. E., Oakes, D., Greenberg, H., Weiss, H. J., Zareba, W., Brown, M. W., Liang, C.-S., Lichstein, E., Little, W. C., Gillespie, J. A., Van Voorhees, L., Krone, R. J., Bodenheimer, M. M., Hochman, J., Dwyer, E. M. Jr, Arora, R., Marcus, F. I., Watelet, L. F. M., Case, R. B. (1999). Thrombogenic Factors and Recurrent Coronary Events. Circulation 99: 2517-2522 [Abstract] [Full Text]  
• van 't Hooft, F. M., Silveira, A., Tornvall, P., Iliadou, A., Ehrenborg, E., Eriksson, P., Hamsten, A. (1999). Two Common Functional Polymorphisms in the Promoter Region of the Coagulation Factor VII Gene Determining Plasma Factor VII Activity and Mass Concentration. Blood 93: 3432-3441 [Abstract] [Full Text]  
• Pahor, M., Elam, M. B., Garrison, R. J., Kritchevsky, S. B., Applegate, W. B. (1999). Emerging Noninvasive Biochemical Measures to Predict Cardiovascular Risk. Arch Intern Med 159: 237-245 [Abstract] [Full Text]  
• Sanders, T. A., de Grassi, T., Miller, G. J, Humphries, S. E (1999). Dietary oleic and palmitic acids and postprandial factor VII in middle-aged men heterozygous and homozygous for factor VII R353Q polymorphism. Am. J. Clin. Nutr. 69: 220-225 [Abstract] [Full Text]  
• Gonzalez-Conejero, R., Lozano, M. L., Rivera, J., Corral, J., Iniesta, J. A., Moraleda, J. M., Vicente, V. (1998). Polymorphisms of Platelet Membrane Glycoprotein Ibalpha Associated With Arterial Thrombotic Disease. Blood 92: 2771-2776 [Abstract] [Full Text]  
• Altshuler, D., Kruglyak, L., Lander, E. (1998). Genetic Polymorphisms and Disease. NEJM 338: 1626-1626 [Full Text]  
• Rosenthal, N., Schwartz, R. S. (1998). In Search of Perverse Polymorphisms. NEJM 338: 122-124 [Full Text]  
• Buetow, K. H., Edmonson, M., MacDonald, R., Clifford, R., Yip, P., Kelley, J., Little, D. P., Strausberg, R., Koester, H., Cantor, C. R., Braun, A. (2001). High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc. Natl. Acad. Sci. USA 98: 581-584 [Abstract] [Full Text]